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Background: Osteoarthritis (OA) is a degenerative joints disorder influenced by genetic predisposition. We reported
that rs11718863 DVWA SNP was represented in Sicilian with a more severe Kellgren and Lawrence (KL) radiographic
grade, displaying its predictive role as OA marker progression. Here, we describe the DVWA SNPs: rs11718863,
rs7639618, rs7651842, rs7639807 and rs17040821 probably able to induce protein functional changes.
Findings: Sixty-one Sicilian patients with knee OA and 100 healthy subjects were enrolled. Clinical and radiographic
evaluation was performed using AKSS scores and KL. Linkage Disequilibrium (LD) analyses were performed in order
to verify whether the SNPs segregate as haplotype. All DVWA SNPs’MinorAllele Frequencies (MAF) were greater
than in the European. The rs7639618 SNP showed a statistical association with KL. Our analyses show that a LD
exists among rs11718863 and rs7639618, as well as between rs7651842, rs7639807 and rs17040821 SNPs. We also
observed that three out of the 161 individuals investigated were simultaneously homozygous carriers of the
rs7651842, rs7639807 and rs17040821 MAF alleles.
Conclusions: In summary, the purpose of this preliminary research was to highlight possible associations between
DVWA SNPs and OA clinical and radiographic data. This work represents a multidisciplinary medicine approach to
study OA where clinical, radiological and genetic evaluation could contribute to better define OA grading.
Keywords: Osteoarthritis, DVWA, Single nucleotide polymorphisms, Haplotypes, KLBackground
Osteoarthritis (OA) is a multifactorial, inflammatory and
degenerative joints disorder characterized by degener-
ation of articular cartilage, intra-articular inflammation
with synovitis, and changes in peri-articular and sub-
chondral bone [1]. OA may be considered in the cat-
egory of polygenic diseases [2-4]. OA diagnosis is mainly
clinical and radiological and X-ray images are the gold
standard to confirm the clinical diagnosis and to grade
the disease [5-7]. Many studies analyzed the correlation
between knee OA radiographic data and clinical status
of the affected joint by using specific clinical scores and
radiographic scales. In this context, the Kellgren and
Lawrence radiographic grading scale (KL) of knee OA,
has been shown to be accurate in OA classification by
several authors [8-12].
Nowadays, molecular genetic investigations have gained
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unless otherwise stated.etiology and have provided evidence for a genetic compo-
nent to OA [13-15]. Thanks to recent genome wide asso-
ciation (GWA) studies, it is known that susceptibility to
OA is influenced by genetic predisposition. Searching for
OA susceptibility loci, it has become apparent that many
of these have particular relevance for the disease develop-
ment at particular skeletal sites and furthermore, some
loci could be linked to the disease, depending on OA pa-
tients ethnic differences [8,16-18].
On the Online Mendelian Inheritance in Man database
(OMIM), which collects human genes and genetic disor-
ders with particular focus on the molecular relationship
between genetic variation and phenotypic expression,
the following polymorphisms and aspartic acid (D) re-
peats are reported as OA susceptibility (OS) sites: FRZB
rs288326 (OS1A) and rs7775 (OS1B), MATN3 rs77245812
(OS2), ASPN D14 repeats (OS3), PTHR2 rs76758470
(OS4), GDF5 rs143383 (OS5) and DVWA rs11718863
(OS6) [19].
Moreover, several associations studies between SNPs
and OA disease remain unconfirmed or controversial,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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affected joint sites, in classification and staging modes.
In turn, to our knowledge, genetic contribution to KL
radiographic severity in knee OA was previously de-
scribed only by our group in Sicilian individuals and by
Valdes et colleagues in UK OA patients and no informa-
tion are available on people from other Europe countries
[20,21].
Considering that polymorphisms are involved in bio-
diversity and could be affected by ethnic heritage and
geographic localization, it becomes of interest to explore
the geographical and ethnic allele distribution, extremely
important in fully understanding the SNP variants effects.
More precisely, Sicilian individuals have a specific genetic
background and different alleles distribution compared to
the rest of Europe (and also compared to the rest of Italy),
probably due to the ethnical, geographic and distinct
gene–environment interactions certainly caused by deep
human migration movements, occurred in Sicily across
centuries as described by several authors [22-25].
Recently, we described that OS5 and OS6 were sta-
tistically associated with clinical features such as KL
radiographic grading scale in Sicilian OA patients, thus
contributing in better define OA grading and progression.
Particularly, we observed that in our cohort of patients,
OS6 genetic alteration (DVWA rs11718863 SNP) was
more represented in patients with more severe OA KL
radiographic grading with poor joint function, displaying
its predictive role as OA marker progression [20].
DVWA gene (gene ID: 344875), also known as COL
6A4P1 (collagen type VI, alpha 4 pseudogene 1), spe-
cifically expressed in cartilage, encodes for a protein
showing double von Willebrand factor A domains (VWA
domain), involved in cellular adhesion and protein-
to-protein interactions [20]. DVWA rs11718863 and
rs7639618 polymorphisms are localized in the same ex-
onic region (the third) and cause missense mutations with
a consequent amino acidic substitution (Tyr169Asn and
Cys260Tyr, respectively). These SNPs were described as
involved in the decrease of the strength interaction be-
tween the DVWA protein and the β-tubulin [26-28], this
protein-protein binding is important in the regulation of
chondrocyte differentiation, which protects articulated
joints from OA onset.
Several DVWA gene functional variants were assayed
by Miyamoto et colleagues in a large GWA association
study. In particular, DVWA rs11718863 SNP is reported
to be strongly associated with risk of knee OA (OR =
1.43 p < 7x10-11) and able to influence β-tubulin binding
in Asian populations [29].
In addition, both Valdes et al. and Meulenbelt et al
showed an association between this genetic alteration
and knee OA in UK population not confirmed for
other European countries. However, the higher risk allelefrequency in the European samples highlighted the ethnic
different penetrance of OA susceptibility genes and,
once again, the need to evaluate the alleles geographic
distribution [26].
Interestingly, as suggested by Miyamoto et al. both
rs11718863 DVWA and rs7639618 polymorphisms could
have a role in etiopathogenesis of OA in Japanese and
Chinese populations. Furthermore, the Tyr169-Cys260
double mutated protein isoform, could have a weaker
binding capacity to β-tubulin and seems to be over-
represented in OA, further suggesting that this interaction
might be fundamental to protect joints from OA [29].
Based on these considerations, in the present work we
wanted to test the association of these two regulative
SNPs with OA disease in our Sicilian cohort and we
evaluated their association with KL grading scale.
To our knowledge, the association between KL and
rs7639618 DVWA SNP has been assayed for the first
time, in this work.
Moreover, even if Valdes et al and Meulenbelt et al an-
alyzed the above-mentioned DVWA SNPs in knee OA
cases, only Miyamoto and colleagues suggested that
rs11718863 and rs7639618 DVWA SNPs might act as
haplotype rather than single SNPs in Japanese and Chinese
OA cohorts [18,26,29]. So, additional investigations are
needed in order to evaluate their role in OA care, accord-
ing to the patients ethnic origin.
Recently, Meulenbelt et al conducted a large replication
study and a meta-analyses of DVWA polymorphisms,
showing that the minor allele frequencies (MAFs) for
these SNPs are much lower in the European individuals
than in Asian ones, even if the Japanese and Chinese pop-
ulations are much more investigated. Additionally, differ-
ent results are reported within the European studies,
probably due to selection criteria, different clinical evalua-
tions, control group selection and geographical localiza-
tions, underlying the need of additional standardization of
the OA phenotypes [21,26-29].
Furthermore, despite the potential functional influence
of these two SNPs on OA etiology and pathogenesis, the
number of scientific papers on this topic is still limited
[4,21,26-38]. Then, it becomes of interest to explore geo-
graphical and ethnic distribution of the polymorphic alleles
considered extremely important for a full understanding of
OA susceptibility risk and to develop proper treatments re-
lated to the individual genetic background.
Patient and methods
Patients
On admission to hospital, sixty-one Sicilian patients, af-
fected with knee primary OA, aged 54-86 years old and
candidates for knee arthroscopy or arthroplasty, were
enrolled in this project. We also enrolled 100 healthy
Sicilian subjects as control samples. This study (named
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tee of the San Raffaele G. Giglio Hospital, Cefalù, Italy
(number of protocol: CE 2011/63) and the patients gave
their written informed consent according to the Helsinki
Declaration.
Clinical and radiographic evaluation
Clinical evaluation was performed for each patient be-
fore surgery using the American Knee Society Score
(AKSS), that includes two sub-scores: Knee Score (KS)
and Function Score (FS) as described previously [20].
The radiographic evaluation was performed on knee
antero-posterior and lateral X-ray views by a single in-
vestigator, using the KL grading scale which includes 4
grades: grade 1 – possible narrowing of joint space (NJS)
and possible presence of osteophytes; grade 2 – definite
NJS and definite osteophytes; grade 3 – definite NJS,
multiple osteophytes, sclerosis, cysts and possible de-
formity of bone contour; grade 4 – marked NJS, large
osteophytes, severe sclerosis, cysts and definite deformity
of bone contour [39,40]. The evaluation was undertaken
on X-ray performed no more than four months before
surgery. In our study we grouped grade 1 and 2 into a
single grade because the radiographic differences in our
cohort were considered not relevant compared to the
ones between KL grade 3 and 4. So, we summarized the
KL classification into 3 groups: A (grade 1 and 2), B
(grade 3), C (grade 4).
Genetic analysis
The patients were genotyped by sequencing analysis
for rs11718863, rs7639618, rs7651842, rs7639807 and
rs17040821 DVWA genetic polymorphisms. Human
Gene Mutation Database (http://www.hgmd.cf.ac.uk)
and dbSNP Short Genetic Variations database (http://
www.ncbi.nlm.nih.gov/snp) were used to analyze gene
regions containing the selected SNPs. Genomic DNA
was extracted from peripheral blood using QIAamp
DNA blood mini kit, according to the manufacturer’s
specifications (Qiagen). After quality and quantity analysis,
DNA was PCR amplified using primers designed by the
Primer3 software (http://fokker.wi.mit.edu/primer3). Pri-
mer sequences used for the abovementioned DVWA
SNPs detection were: 5’-aggctgcctgccattattctt-3’ and 5’-
cccatgctgtttcctttgaaca -3’for forward and reverse primers
respectively. PCR reactions were performed with 50 ng of
genomic DNA in a total volume of 50 μL containing 1X
PCR Gold Buffer, 1.5 mM di MgCl2, 200 μM dNTPs, 200
nM of forward and reverse primer mix, 1.25 U of Ampli-
Taq Gold DNA Polymerase (Applied Biosystems). The
thermal cycle profile employed a 5-min denaturing step at
94°C, followed by 35 cycles at 94°C for 45 sec, 59°C for 45
sec, 72°C for 45 sec and a final extension step of 5 min at
72°C. Quality and quantity of PCR products were assessedon Bioanalyzer instrument (Agilent Technologies) and
were purified using QIAquick PCR purification kit, ac-
cording to the manufacturer’s specifications (Qiagen). To
perform DNA sequencing, purified amplicons (924 bp)
were labelled with BigDye Terminator v3.1 Cycle Sequen-
cing Kit following the manufacturer’s standard protocol
(Applied Biosystems). The thermal cycle profile employed
1 min denaturing step at 96°C, followed by 25 cycles at
96°C for 10 sec, 54°C for 5 sec, 60°C for 3 min. Labelled
samples were purified with X-terminator purification kit
according to manufacturer’s standard protocol and loaded
in 3500-Dx Genetic Analyzer (Applied Biosystems) for
separation by capillary electrophoresis. Electropherograms
and sequence files were analyzed using Sequencing Ana-
lysis and SeqScape softwares (Applied Biosystems).
Statistical analysis
The association between DVWA SNPs genotypes and
KL groups, was analyzed using GraphPad InStat soft-
ware version 3.05 (San Diego California USA) as previ-
ously described [20,25]. Mann Whitney-U test, Pearson’s
Chi-Square test and Fisher’s exact test were performed.
Differences in groups were considered significant when
the p-value was less than or equal to 0.05. Hardy-
Weinberg Equilibrium (HWE) was calculated. Finally, in
order to verify the degree of allelic segregation among
the SNPs of our interest, we calculated the Linkage Dis-
equilibrium (LD) coefficients (D’ and r2) using Haplo-
view software 3.32.
Findings
Clinical and radiographic evaluation
We recruited 61 cases, 36 females and 25 males, and
they were divided into 3 groups (A, B, C) depending on
the degree of radiographic knee OA.
According to the clinical scores we classified the pa-
tients as follows:
– Group A consisted of 20 patients, 11 females and 9
males,
– Group B consisted of 21 patients, 15 females and 6
males,
– Group C consisted of 20 patients, 10 females and 10
males.
Linkage disequilibrium analysis
Firstly, in order to verify the degree of allelic segregation
among the SNPs of our interest, we calculated the Link-
age Disequilibrium (LD) coefficients (D’ and r2) using
Haploview software 3.32. Based on the HapMap project
databases [41-43], this approach was used for rs7639618,
rs7639807, rs7651842 by a pairwise tagging mode, be-
cause allelic frequencies from different populations are
available on this platform for these three SNPs. Instead,
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and rs11718863.
Then, we replicated the D’ and r2 calculation for all
the five above-mentioned SNPs, by using the allelic fre-
quencies from our Sicilian cohort of healthy subjects,
with the proper formulas: D’ = D/Dmax, and r2 = D2/
p1p2q1q2 where, D = (x11)(x22) – (x12)(x21); Dmax is
the smaller of p1q2 and p2q1, where the haplotype fre-
quencies for the hypothetic loci A and B are defined as
described in the Table 1. For our Sicilian cohort, the
pairwise LDs for rs7639618, rs7639807 and rs7651842
perfectly matched with those observed by Haploview
software (Table 1).
Finally, similarly to the Haploview LD output form, we
elaborated a r2 LD plot, where the perfect LD between
SNPs pair is described by r2 = 1 and is dark marked,
whereas the LD absence is described by r2 = 0 and is
white marked (Figure 1).
Mutational analysis of OA susceptibility genes
Genotyping analyses were performed by sequencing ana-
lysis of amplicons of 924 bp, containing the two DVWA
SNPs: rs11718863, rs7639618. Sequencing analysis of the
electropherograms revealed the presence of others three
less known DVWA SNPs: rs7651842, rs7639807 and
rs17040821. Sixty-one osteoarthritis patients and one
hundred healthy subjects were genotyped for the above-
mentioned five DVWA SNPs. Percentages of the wild type
(WT), heterozygote (H) and homozygote (MUT) geno-
types for each polymorphism were calculated. SNPs, geno-
type percentages and allele frequencies of 161 individuals
investigated in this study are also reported (Table 2). For
OA patients, we reported genotyping data of the three
radiographic groups (A, B, C) and the number of individ-
uals for each genotype. Deviations of Hardy-Weinberg
equilibrium for all polymorphisms analyzed were not ob-
served (Table 3).
KL and genotype association analysis
To evaluate a potential association between genotypes,
WT group or Mutated (Mut + H) one and the KL groups
(A, B, C), Mann Whitney-U test, Chi-Square test and
Fisher’s exact test were performed (Table 4). Analysis
showed a statistically significant association between ge-
notype and KL grading scale for the rs11718863 andTable 1 Haplotype and allele frequencies used for
Linkage Disequilibrium analyses
Haplotype Frequency Allele Frequency
A1B1 x11 A1 p1 = x11 + x12
A1B2 x12 A2 p2 = x21 + x22
A2B1 x21 B1 q1 = x11 + x21
A2B2 x22 B2 q2 = x12 + x22rs7639618 DVWA polymorphisms (p = 0.03). These re-
sults are in line with the study of Valdes AM et al [21],
where these polymorphisms are associated with the risk
of knee OA in the UK population, but to our knowledge,
this is the first study that reports the simultaneous pres-
ence of these two genetic alterations associated with KL
in a Sicilian group. Finally, it is possible to note in
Table 4, that rs11718863 and rs7639618 DVWA SNPs
(genotype H +Mut) are more represented in group C
(55%), compared to the other two groups A (25%) and B
(19%), suggesting that they can be associated with a
more severe OA radiographic grade.
For rs7651842, rs7639807 and rs17040821 DVWA SNPs,
we did not observed significant statistical association with
radiographic KL grade (Table 4).
Discussion
Nowadays, molecular genetic investigations have gained
an increasingly significant role in the completion of OA
etiology and provided evidence for a genetic contribute
to OA. We previously reported a relationship between
genetic, clinical and radiographic features in OA disease,
and we suggested to evaluate OS5 and OS6 SNPs as bio-
markers of OA grading and progression [20].
In this work, we recruited 61 OA Sicilian cases divided
into 3 groups (A, B and C), based on degree of KL radio-
graphic knee OA and 100 healthy individuals, from the
same geographic area.
Concerning the rs11718863 (OS6) and rs7639618
DVWA genetic polymorphisms, alleles frequencies ana-
lyzed in this work were different in the Sicilian group with
respect to those reported in dbSNP database for European
individuals of various geographic areas (Figure 2). In line
with data obtained by Meulenbelt et al. and Valdes et al
[21], the MAF for these SNPs were much lower in the
European samples than in Asian ones. In addition, for the
two above-mentioned genetic alterations, we have shown
that MAF values were greater in the Sicilian individuals
than in the European ones: 18% rather than 14.6% and
13%, according to data reported by Valdes and colleagues
[21] and in SNPs database respectively [26].
It is well known that polymorphisms are involved in
biodiversity and could be affected by ethnic heritage and
geographic localization. In order to evaluate their hypo-
thetical roles in human disease, such as OA, different
geographical regions should be investigated to ascertain
biodiversity and to fully understand the SNP variant
effects.
Interestingly, a perfect genotypic correspondence (100%
of the cases) has been displayed in all of the 161 indi-
viduals investigated, between rs11718863 and rs7639618
DVWA SNPs. In other words, all individuals are double
WT or double H or double MUT carriers. In order to ve-
rify the degree of allelic segregation among these SNPs,
Figure 1 This figure display the r2 LD plot, where the perfect LD between SNPs pair is (r2 = 1) dark marked, whereas the LD absence
(r2 = 0) is white marked.
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r2 test, according to the observation of a coinheritance
of SNP alleles strongly suggests that rs11718863 and
rs7639618 DVWA SNPs, segregate as haplotype (r2 = 1)
(Figure 1), in line with data published by Miyamoto and
colleagues, but for the first time described in Sicilian
individuals analyzed in our study [29]. Considering that
rs11718863 DVWA SNP is marked as susceptibility
site, and that we have shown that it is in LD with
rs7639618 DVWA, we suggest to assay also this genetic
alteration in OA patients in order to define the func-
tional role of DVWA in OA grading and progression.
In addition, even for rs7651842, rs7639807 and
rs17040821, sequencing data analysis have displayed a
perfect genotypic correspondence (100% of the cases) in
all of the 161 individuals investigated. In other words,
all individuals were triple WT or triple H or triple MUT
carriers. Interestingly, three of the 161 individuals inves-
tigated were triple MUT, also taking into consideration
that in the literature data these genotypes occur separ-
ately at low percentages (rs7651842: 0.9%; rs7639807:1.7%; rs17040821:1.7%). Therefore, we calculated r2 LD
coefficient, using a pairwise approach which resulted
r2 = 1 in every SNP pair analyzed, suggesting that the
above-mentioned SNPs segregate as haplotype (Figure 1).
To our knowledge, these assumptions have been described
for the first time in a cohort of Sicilian individuals, even if
a not perfect haplotype segregation is expected, consider-
ing the MAFs reported in dbSNP database. Moreover, the
observation that no MAF alleles are detected in dbSNP
database for the Asian population, supports the need of
additional studies on Caucasian or Sicilian individuals to
better investigate the role of rs7651842, rs7639807 and
rs17040821 SNPs and their possible contribution on
DVWA protein functional changes and their impact on
OA susceptibility in people of other geographic areas.
We recently reported that rs11718863 was statistically
associated with KL values in a cohort of Sicilian OA pa-
tients and also that this genetic alteration was more rep-
resented in individuals with more severe knee OA KL
radiographic grading. In order to extend the association
with KL grade also for the rs7639618 DVWA SNP, we
Table 3 Genetic analysis results according to KL grading groups
KL grading groups
DVWA polymorphism Genotype A group n = 20 % HWE B group n = 21 % HWE C group n = 20 % HWE
rs11718863
TT WT 15 75 17 81 9 45
TA H 4 20 0,33 4 19 0,63 10 50 0,39
AA MUT 1 5 0 0 1 5
rs7639618
GG WT 15 75 17 81 9 45
GA H 4 20 0,33 4 19 0,63 10 50 0,39
AA MUT 1 5 0 0 1 5
rs7651842
AA WT 14 70 15 71,4 15 75
AG H 6 30 0,43 5 23,8 0,51 4 20 0,33
GG MUT 0 1 4,8 1 5
rs7639807
GG WT 14 70 15 71,4 15 75
GA H 6 30 0,43 5 23,8 0,51 4 20 0,33
AA MUT 0 1 4,8 1 5
rs17040821
CC WT 14 70 15 71,4 15 75
CT H 6 30 0,43 5 23,8 0,51 4 20 0,33
TT MUT 0 1 4,8 1 5
Table 2 Genetic analysis results
DVWA polymorhism Genotype OA patients n = 61 % Allele frequencies % Controls n = 100 % Allele frequencies %
rs11718863
TT WT 41 67 T = 100 82 72 72 T = 100 72
TA H 18 30 A = 22 18 25 25 A = 56 28
AA MUT 2 3 3 3
rs7639618
GG WT 41 67 G = 100 82 72 72 G = 144 72
GA H 18 30 A = 22 18 25 25 A = 56 28
AA MUT 2 3 3 3
rs7651842
AA WT 44 72,1 A = 103 84,4 85 85 A = 170 85
AG H 15 24,6 G = 19 15,6 14 14 G = 30 15
GG MUT 2 3,3 1 1
rs7639807
GG WT 44 72,1 A = 103 84,4 85 85 G = 170 85
GA H 15 24,6 G = 19 15,6 14 14 A = 30 15
AA MUT 2 3,3 1 1
rs17040821
CC WT 44 72,1 C = 103 84,4 85 85 C = 170 85
CT H 15 24,6 T = 19 15,6 14 14 T = 30 15
TT MUT 2 3,3 1 1
n = number of patients.
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Table 4 Genotype and alleles statistical association with KL grade
KL and genotype KL and alleles
DVWA polymorphism WT % H/Mut % p-value* Allele T % Allele A % p-value*
A 15 75 5 25 A 34 85 6 15
rs11718863 B 17 81 4 19 0,03 B 38 90,5 4 9,5 0,04
C 9 45 11 55 C 28 70 12 30
Allele G Allele A
A 15 75 5 25 A 34 85 6 15
rs7639618 B 17 81 4 19 0,03 B 38 90,5 4 9,5 0,04
C 9 45 11 55 C 28 70 12 30
Allele A Allele G
A 14 70 6 30 A 34 85 6 25
rs7651842 B 15 71,4 6 28,6 0,936 B 35 83,3 7 16,7 0,9713
C 15 75 5 25 C 34 85 6 25
Allele G Allele A
A 14 70 6 30 A 34 85 6 25
rs7639807 B 15 71,4 6 28,6 0,936 B 35 83,3 7 16,7 0,9713
C 15 75 5 25 C 34 85 6 25
Allele C Allele T
A 14 70 6 30 A 34 85 6 25
rs17040821 B 15 71,4 6 28,6 0,936 B 35 83,3 7 16,7 0,9713
C 15 75 5 25 C 34 85 6 25
*Chi-Squared Test.
Figure 2 SNPs alleles frequencies and MAF values for individuals of various geographic areas.
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tion among the KL OA groups showing a significant as-
sociation between rs7639618 and KL in our OA patients
cohort.
Sequencing analysis of the electropherograms revealed
the presence of other three less known DVWA SNPs:
rs7651842, rs7639807 and rs17040821, for which no lit-
erature data were available. Also for these SNPs, MAF
values were approximately three fold greater in the Sicilian
individuals than in the European ones (Figure 2).
Unlike rs11718863 and rs7639618, these polymor-
phisms are not marked as clinically relevant in dbSNP
database probably due to absence of bibliographic data.
These three genetic alterations are located in the same
exonic region of DVWA gene and for this reason we
hypothesize that they could cause protein functional
changes, not still investigated.
Finally, in our study a high percentage of the 161 Sicilian
individuals are carriers of DVWA SNPs mutated alleles.
In particular, 29.8% were H or homozygous MUT for
rs11718863 (OS6) and rs7639618, whereas, 19.9% were
H or homozygous MUT for rs7651842, 7639807 and
rs17040821 SNPs.
A limitation of this study may be our small sample size.
This may influence the generalizability of these findings;
however, our results are representative of patients with
mild to moderate knee OA. In addition, the positive asso-
ciation described in this paper could represent a prelimin-
ary study that highlights DVWA gene role in OA patients
and in particular, for Sicilian individuals.
Summing up, DVWA gene was recently related to OA
through a genome wide association study in the Japanese
population. Today, a very limited number of reports have
clarified its molecular role on cartilage homeostasis, even
if some authors and association studies have supposed its
role in OA etiopathogenesis [4,26,27,28,29,31-40]. Add-
itional studies are needed to clarify the SNPs contribution
to functional protein modifications, also to highlight
which SNPs are more important on OA susceptibility in
different geographic areas.
Conclusion
Highlighting genetic basis of human disease could con-
tribute to improve personalized treatments [44,45]. OA
is the most common joint disorder affecting large seg-
ments of the population and leading to significant dis-
ability and impaired quality of life. The purpose of this
preliminary research was to highlight possible associations
between DVWA SNPs and OA clinical and radiographic
data. There are several lines of evidence indicating that
genetic abnormalities can result in early onset of OA. In
this work we genotyped 61 OA patients and 100 control
samples. For all the DVWA SNPs investigated, the MAF
values were higher in our Sicilian cohort than in theEuropean one. Additional studies are needed in order
to clarify these SNPs distribution in people of different
geographic areas. As previously described for rs11718863
SNP, also the rs7639618 polymorphism has shown a stat-
istical association with KL grade, but not observed for the
rs7651842, rs7639807 and rs17040821. Thus, we suggest
to test also the rs7639618 SNP in OA patients. This work
represents a multidisciplinary and translational medicine
approach to study OA where clinical, radiographic and
genetic evaluation could contribute to better define the
disease grading and progression for the development of
new therapies.
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